Sign Up

MIRA

COM:MIRAPHARMACEUTICALS

MIRA Pharmaceuticals

  • Stock

USD

Last Close

1.26

22/11 21:00

Market Cap

8.27M

Beta: -

Volume Today

359.54K

Avg: -

OverviewAnalysisMetricsFinancialsFilingsAPIChartData
Income StatementBalance SheetCash FlowKey MetricsRatios
Quarterly
Yearly

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe NowHelp
Dec '20
Dec '21
Dec '22
Dec '23
average inventory
average payables
578.25K
-
464.04K
19.75%
average receivables
40.51K
-
book value per share
-0.00
-
0.15
3,741.13%
-0.04
126.37%
0.24
682.67%
capex per share
capex to depreciation
capex to operating cash flow
capex to revenue
cash per share
0.00
-
0.19
80,379.86%
0.02
87.51%
0.25
941.47%
days of inventory on hand
days payables outstanding
days sales outstanding
debt to assets
3.18
-
0.09
97.26%
0.57
555.41%
0.00
99.82%
debt to equity
-1.45
-
0.13
108.94%
-0.82
735.74%
0.00
100.14%
dividend yield
earnings yield
-0.00
-
-0.02
3,101.12%
-0.07
224.29%
-0.61
724.37%
enterprise value
94.75M
-
92.15M
2.75%
94.80M
2.88%
14.90M
84.29%
enterprise value over ebitda
-1.40K
-
-42.82
96.94%
-13.45
68.58%
-0.90
93.33%
ev to operating cash flow
-1.39K
-
-66.96
95.19%
-16.91
74.74%
-3.29
80.57%
ev to sales
free cash flow per share
-0.00
-
-0.09
1,923.97%
-0.38
307.28%
-0.24
35.78%
free cash flow yield
-0.00
-
-0.01
1,923.97%
-0.06
307.28%
-0.23
292.69%
graham net net
-0.01
-
0.12
2,075.00%
-0.07
164.31%
0.22
395.50%
graham number
0.02
-
0.71
3,314.04%
0.66
7.53%
1.85
180.29%
income quality
1
-
0.63
36.77%
0.79
25.59%
0.38
52.37%
intangibles to total assets
0
-
0
0
0
interest coverage
-185.80
-
-88.30
52.48%
-687.60
678.74%
4.80
100.70%
interest debt per share
0.01
-
0.02
251.29%
0.03
57.98%
-0.19
646.57%
inventory turnover
invested capital
-1.45
-
0.13
108.94%
-0.82
735.74%
0.00
100.14%
market cap
94.66M
-
94.66M
0%
94.66M
0%
19.49M
79.41%
net current asset value
-86.87K
-
1.82M
2,190.12%
-959.90K
152.87%
4.30M
547.98%
net debt to ebitda
-1.28
-
1.17
191.41%
-0.02
101.70%
0.28
1,491.88%
net income per share
-0.00
-
-0.15
3,101.12%
-0.48
224.29%
-0.65
34.83%
operating cash flow per share
-0.00
-
-0.09
1,923.97%
-0.38
307.28%
-0.24
35.78%
payables turnover
receivables turnover
research and ddevelopement to revenue
return on tangible assets
-2.41
-
-0.65
73.04%
-8.23
1,167.99%
-2.43
70.47%
revenue per share
roe
1.09
-
-0.96
187.92%
11.84
1,329.93%
-2.74
123.14%
roic
-2.42
-
-0.84
65.25%
-27.84
3,204.23%
-3.79
86.40%
sales general and administrative to revenue
shareholders equity per share
-0.00
-
0.15
3,741.13%
-0.04
126.37%
0.24
682.67%
stock based compensation to revenue
tangible asset value
-62.11K
-
2.26M
3,741.13%
-596.23K
126.37%
4.37M
833.67%
tangible book value per share
-0.00
-
0.15
3,741.13%
-0.04
126.37%
0.24
682.67%
working capital
-86.87K
-
1.82M
2,190.12%
-875.63K
148.22%
4.30M
591.09%

All numbers in USD (except ratios and percentages)